MIME-Version: 1.0
Date: Tue, 26 May 2020 14:10:56 -0400
References: <CACNgykPf85sxHJX+NXztwqed0aqzYoe9vYFSYtG_DNH0piEfqg@mail.gmail.com>
	<CACNgykNHMqXsHUUgGBK=1QkiSmA-hm3UTwzfSZ1zWeT_tgoCmA@mail.gmail.com>
In-Reply-To: <CACNgykNHMqXsHUUgGBK=1QkiSmA-hm3UTwzfSZ1zWeT_tgoCmA@mail.gmail.com>
Message-ID: <CACNgykN_Vnizi3Ou4jk-pwTA1y00xqHHaJjXZh2vVMc_OHYYmw@mail.gmail.com>
Subject: Re: On rec. of Simon Milner at Miller Insurance
From: Josh Klein <josh@josh.is>
To: cristina.varner@theabdteam.com
Content-Type: multipart/alternative; boundary="000000000000595b9605a69104ce"

--000000000000595b9605a69104ce
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

Giving this one last shot; let me know if you're available sometime in the
coming weeks!

All best,
Josh
=E1=90=A7

On Mon, May 18, 2020 at 6:08 PM Josh Klein <josh@josh.is> wrote:

> Just following up - let me know if I can provide any further info.
>
> best,
> Josh
>
> On Fri, May 8, 2020 at 11:16 AM Josh Klein <josh@josh.is> wrote:
> >
> > You were suggested as a good person to contact reg. clinical trials for
> Continuous Glucose Monitors; I've been in discussion with Abbot and am
> curious to talk to someone in the US who can help me understand what an
> insurer might look for. Do you have time for a brief call in the next
> couple weeks?
> >
> > All best wishes,
> > Josh
> > =E1=90=A7
>

--000000000000595b9605a69104ce
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr">Giving this one last shot; let me know if you&#39;re avail=
able sometime in the coming=C2=A0weeks!<div><br></div><div>All best,<br>Jos=
h</div></div><div hspace=3D"streak-pt-mark" style=3D"max-height:1px"><img a=
lt=3D"" style=3D"width:0px;max-height:0px;overflow:hidden" src=3D"https://m=
ailfoogae.appspot.com/t?sender=3Daam9zaEBqb3NoLmlz&amp;type=3Dzerocontent&a=
mp;guid=3D55e32b28-ae33-4d09-a36b-2614d6816206"><font color=3D"#ffffff" siz=
e=3D"1">=E1=90=A7</font></div><br><div class=3D"gmail_quote"><div dir=3D"lt=
r" class=3D"gmail_attr">On Mon, May 18, 2020 at 6:08 PM Josh Klein &lt;<a h=
ref=3D"mailto:josh@josh.is">josh@josh.is</a>&gt; wrote:<br></div><blockquot=
e class=3D"gmail_quote" style=3D"margin:0px 0px 0px 0.8ex;border-left:1px s=
olid rgb(204,204,204);padding-left:1ex">Just following up - let me know if =
I can provide any further info.<br>
<br>
best,<br>
Josh<br>
<br>
On Fri, May 8, 2020 at 11:16 AM Josh Klein &lt;<a href=3D"mailto:josh@josh.=
is" target=3D"_blank">josh@josh.is</a>&gt; wrote:<br>
&gt;<br>
&gt; You were suggested as a good person to contact reg. clinical trials fo=
r Continuous Glucose Monitors; I&#39;ve been in discussion with Abbot and a=
m curious to talk to someone in the US who can help me understand what an i=
nsurer might look for. Do you have time for a brief call in the next couple=
 weeks?<br>
&gt;<br>
&gt; All best wishes,<br>
&gt; Josh<br>
&gt; =E1=90=A7<br>
</blockquote></div>

--000000000000595b9605a69104ce--